Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia

Paolo Calabresi, Letizia M. Cupini, Diego Centonze, Francesco Pisani, Giorgio Bernardi

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

Several new antiepileptic drugs (AEDs) have been introduced for clinical use recently. These new AEDs, as did the classic AEDs, target multiple cellular sites both pre- and postsynaptically. The major common goal of the pharmacological treatment using AEDs is to counteract abnormal brain excitability by either decreasing excitatory transmission or enhancing neuronal inhibition. Interestingly, an excessive release of excitatory amino acids and a reduced neuronal inhibition also occur in brain ischemia. Thus, recently, the use of AEDs as a possible neuroprotective strategy in brain ischemia is receiving increasing attention, and many AEDs have been tested in animal models of stroke, providing encouraging results. Experimental studies utilizing global or focal ischemia in rodents have provided insights into the possible neuroprotective action of the various AEDs. However, the implication of these studies in the treatment of acute stroke in humans is not always direct. In fact, various clinical studies with drugs targeting the same voltage- and ligand-gated channels modulated by most of the AEDs failed to show neuroprotection. The differential mechanisms that underlie the development of focal ischemic injury in experimental animal models versus human stroke require further investigation to open a new therapeutic perspective for neuroprotection that might be applicable in the future.

Original languageEnglish
Pages (from-to)693-702
Number of pages10
JournalAnnals of Neurology
Volume53
Issue number6
DOIs
Publication statusPublished - Jun 1 2003

Fingerprint

Brain Ischemia
Anticonvulsants
Stroke
Animal Models
Ligand-Gated Ion Channels
Excitatory Amino Acids
Drug Delivery Systems
Rodentia
Therapeutics
Ischemia
Pharmacology
Wounds and Injuries
Brain

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. / Calabresi, Paolo; Cupini, Letizia M.; Centonze, Diego; Pisani, Francesco; Bernardi, Giorgio.

In: Annals of Neurology, Vol. 53, No. 6, 01.06.2003, p. 693-702.

Research output: Contribution to journalArticle

Calabresi, Paolo ; Cupini, Letizia M. ; Centonze, Diego ; Pisani, Francesco ; Bernardi, Giorgio. / Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. In: Annals of Neurology. 2003 ; Vol. 53, No. 6. pp. 693-702.
@article{8426fe6f304340378480b50be6dec25f,
title = "Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia",
abstract = "Several new antiepileptic drugs (AEDs) have been introduced for clinical use recently. These new AEDs, as did the classic AEDs, target multiple cellular sites both pre- and postsynaptically. The major common goal of the pharmacological treatment using AEDs is to counteract abnormal brain excitability by either decreasing excitatory transmission or enhancing neuronal inhibition. Interestingly, an excessive release of excitatory amino acids and a reduced neuronal inhibition also occur in brain ischemia. Thus, recently, the use of AEDs as a possible neuroprotective strategy in brain ischemia is receiving increasing attention, and many AEDs have been tested in animal models of stroke, providing encouraging results. Experimental studies utilizing global or focal ischemia in rodents have provided insights into the possible neuroprotective action of the various AEDs. However, the implication of these studies in the treatment of acute stroke in humans is not always direct. In fact, various clinical studies with drugs targeting the same voltage- and ligand-gated channels modulated by most of the AEDs failed to show neuroprotection. The differential mechanisms that underlie the development of focal ischemic injury in experimental animal models versus human stroke require further investigation to open a new therapeutic perspective for neuroprotection that might be applicable in the future.",
author = "Paolo Calabresi and Cupini, {Letizia M.} and Diego Centonze and Francesco Pisani and Giorgio Bernardi",
year = "2003",
month = "6",
day = "1",
doi = "10.1002/ana.10603",
language = "English",
volume = "53",
pages = "693--702",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia

AU - Calabresi, Paolo

AU - Cupini, Letizia M.

AU - Centonze, Diego

AU - Pisani, Francesco

AU - Bernardi, Giorgio

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Several new antiepileptic drugs (AEDs) have been introduced for clinical use recently. These new AEDs, as did the classic AEDs, target multiple cellular sites both pre- and postsynaptically. The major common goal of the pharmacological treatment using AEDs is to counteract abnormal brain excitability by either decreasing excitatory transmission or enhancing neuronal inhibition. Interestingly, an excessive release of excitatory amino acids and a reduced neuronal inhibition also occur in brain ischemia. Thus, recently, the use of AEDs as a possible neuroprotective strategy in brain ischemia is receiving increasing attention, and many AEDs have been tested in animal models of stroke, providing encouraging results. Experimental studies utilizing global or focal ischemia in rodents have provided insights into the possible neuroprotective action of the various AEDs. However, the implication of these studies in the treatment of acute stroke in humans is not always direct. In fact, various clinical studies with drugs targeting the same voltage- and ligand-gated channels modulated by most of the AEDs failed to show neuroprotection. The differential mechanisms that underlie the development of focal ischemic injury in experimental animal models versus human stroke require further investigation to open a new therapeutic perspective for neuroprotection that might be applicable in the future.

AB - Several new antiepileptic drugs (AEDs) have been introduced for clinical use recently. These new AEDs, as did the classic AEDs, target multiple cellular sites both pre- and postsynaptically. The major common goal of the pharmacological treatment using AEDs is to counteract abnormal brain excitability by either decreasing excitatory transmission or enhancing neuronal inhibition. Interestingly, an excessive release of excitatory amino acids and a reduced neuronal inhibition also occur in brain ischemia. Thus, recently, the use of AEDs as a possible neuroprotective strategy in brain ischemia is receiving increasing attention, and many AEDs have been tested in animal models of stroke, providing encouraging results. Experimental studies utilizing global or focal ischemia in rodents have provided insights into the possible neuroprotective action of the various AEDs. However, the implication of these studies in the treatment of acute stroke in humans is not always direct. In fact, various clinical studies with drugs targeting the same voltage- and ligand-gated channels modulated by most of the AEDs failed to show neuroprotection. The differential mechanisms that underlie the development of focal ischemic injury in experimental animal models versus human stroke require further investigation to open a new therapeutic perspective for neuroprotection that might be applicable in the future.

UR - http://www.scopus.com/inward/record.url?scp=0038443830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038443830&partnerID=8YFLogxK

U2 - 10.1002/ana.10603

DO - 10.1002/ana.10603

M3 - Article

C2 - 12783414

AN - SCOPUS:0038443830

VL - 53

SP - 693

EP - 702

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 6

ER -